Lars Ekman
CIK 1376117 · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$507.4K
Companies
6
Total Filings
71
Lifetime Open-Market Net
-$15.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRTA | Director | 3,148 | $9.22 | $29.0K | -$7.55M | 20 | 2026-05-15 |
| AMRN | Director | 0 | $14.01 | $0 | -$7.47M | 17 | 2022-06-29 |
| RARE | Director | 17,745 | $26.96 | $478.4K | $0 | 8 | 2022-06-28 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| SOPHIRIS BIO INC. (SPHS) Delisted | Director | 520 | — | — | -$4.5K | 7 | 2019-06-28 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | Director | — | — | — | $0 | 3 | 2010-05-03 |
Recent Filings · Page 5 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-13 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2016-06-14 | RARE | Grant (A) | +1,875 | $0 | EDGAR |
| 2016-06-03 | Spark Therapeutics, Inc. (ONCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-31 | SOPHIRIS BIO INC. (SPHS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-24 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2016-03-21 | RARE | Grant (A) | — | $0 | EDGAR |
| 2015-11-25 | PRTA | Mixed | — | -$2.01M | EDGAR |
| 2015-07-08 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2015-05-28 | SOPHIRIS BIO INC. (SPHS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-26 | PRTA | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.